Also known as: Fujifilm
Fujifilm is a Japanese multinational conglomerate operating across imaging, document solutions, medical systems, biotechnology, and related chemical technologies. Founded in 1934 and headquartered in Tokyo, it evolved from photographic film into diversified healthcare and industrial businesses. The company is publicly traded in Japan under ticker 4901.
The FDA extended by three months the review period for Savara's MOLBREEVI biologics license application in autoimmune pulmonary alveolar proteinosis, moving the PDUFA date to Nov. 22, 2026. Savara had previously said the FDA filed the application after a resubmission tied to manufacturing data and a transfer to Fujifilm.
Savara Inc. announced the FDA has accepted its resubmitted Biologics License Application for MOLBREEVI, a treatment for autoimmune pulmonary alveolar proteinosis, with Priority Review granted and a target decision date of August 22, 2026.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07587619 |
Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion |
ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
